188 related articles for article (PubMed ID: 26079381)
1. In Vitro-Stimulated IL-6 Monocyte Secretion and In Vivo Peripheral Blood T Lymphocyte Activation Uniquely Predicted 15-Year Survival in Patients with Head and Neck Squamous Cell Carcinoma.
Aarstad HH; Vintermyr OK; Ulvestad E; Kross K; Heimdal JH; Aarstad HJ
PLoS One; 2015; 10(6):e0129724. PubMed ID: 26079381
[TBL] [Abstract][Full Text] [Related]
2. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH
APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083
[TBL] [Abstract][Full Text] [Related]
3. In vitro Monocyte IL-6 Secretion Levels Following Stimulation with Autologous Spheroids Derived from Tumour or Benign Mucosa Predict Long-term Survival in Head and Neck Squamous Cell Carcinoma Patients.
Aarstad HJ; Aarstad HH; Vintermyr OK; Kross KW; Lybak S; Heimdal JH
Scand J Immunol; 2017 Mar; 85(3):211-219. PubMed ID: 27943380
[TBL] [Abstract][Full Text] [Related]
4. Stimulated monocyte IL-6 secretion predicts survival of patients with head and neck squamous cell carcinoma.
Heimdal JH; Kross K; Klementsen B; Olofsson J; Aarstad HJ
BMC Cancer; 2008 Jan; 8():34. PubMed ID: 18234094
[TBL] [Abstract][Full Text] [Related]
5. Presence of activated T lymphocytes in peripheral blood of head and neck squamous cell carcinoma patients predicts impaired prognosis.
Aarstad HJ; Heimdal JH; Klementsen B; Olofsson J; Ulvestad E
Acta Otolaryngol; 2006 Dec; 126(12):1326-33. PubMed ID: 17101596
[TBL] [Abstract][Full Text] [Related]
6. Peripheral blood mononuclear cell (PBMC) responsiveness in patients with head and neck cancer in relation to tumour stage and prognosis.
Heimdal JH; Aarstad HJ; Klementsen B; Olofsson J
Acta Otolaryngol; 1999 Mar; 119(2):281-4. PubMed ID: 10320092
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood T-lymphocyte and monocyte function and survival in patients with head and neck carcinoma.
Heimdal JH; Aarstad HJ; Olofsson J
Laryngoscope; 2000 Mar; 110(3 Pt 1):402-7. PubMed ID: 10718427
[TBL] [Abstract][Full Text] [Related]
8. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
[TBL] [Abstract][Full Text] [Related]
9. Anti-CD3/anti-CD28 monoclonal antibody-coated suture enhances the immune response of patients with head and neck squamous cell carcinoma.
Shibuya TY; Wei WZ; Zormeier M; Ensley J; Sakr W; Mathog RH; Meleca RJ; Yoo G; June CH; Levine B; Lum LG
Arch Otolaryngol Head Neck Surg; 1999 Nov; 125(11):1229-34. PubMed ID: 10555694
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo interleukin (IL)-1 beta, IL-6, IL-12 and tumor necrosis factor-alpha responsiveness with monocytes from patients with head and neck carcinoma.
Heimdal JH; Aarstad HJ; Klementsen B; Olofsson J
Eur Arch Otorhinolaryngol; 1999; 256(5):250-6. PubMed ID: 10392301
[TBL] [Abstract][Full Text] [Related]
11. Anti-CD3/anti-CD28 bead stimulation overcomes CD3 unresponsiveness in patients with head and neck squamous cell carcinoma.
Shibuya TY; Wei WZ; Zormeier M; Ensley J; Sakr W; Mathog RH; Meleca RJ; Yoo GH; June CH; Levine BL; Lum LG
Arch Otolaryngol Head Neck Surg; 2000 Apr; 126(4):473-9. PubMed ID: 10772300
[TBL] [Abstract][Full Text] [Related]
12. Production by human squamous cell carcinoma of a factor inducing activation and proliferation of immune cells.
Hirabayashi H; Yasumura S; Lin WC; Amoscato A; Johnson JT; Herberman RB; Whiteside TL
Arch Otolaryngol Head Neck Surg; 1995 Mar; 121(3):285-92. PubMed ID: 7873144
[TBL] [Abstract][Full Text] [Related]
13. A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17(+) cell frequency.
Punt S; Dronkers EA; Welters MJ; Goedemans R; Koljenović S; Bloemena E; Snijders PJ; Gorter A; van der Burg SH; Baatenburg de Jong RJ; Jordanova ES
Cancer Immunol Immunother; 2016 Apr; 65(4):393-403. PubMed ID: 26899388
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive T-cell immunophenotyping and next-generation sequencing of human papillomavirus (HPV)-positive and HPV-negative head and neck squamous cell carcinomas.
Poropatich K; Fontanarosa J; Swaminathan S; Dittmann D; Chen S; Samant S; Zhang B
J Pathol; 2017 Nov; 243(3):354-365. PubMed ID: 28771750
[TBL] [Abstract][Full Text] [Related]
15. Squamous carcinoma cells influence monocyte phenotype and suppress lipopolysaccharide-induced TNF-alpha in monocytes.
Lam-ubol A; Hopkin D; Letuchy EM; Kurago ZB
Inflammation; 2010 Aug; 33(4):207-23. PubMed ID: 20084448
[TBL] [Abstract][Full Text] [Related]
16. Co-culture of head and neck squamous cell carcinoma spheroids with autologous monocytes predicts prognosis.
Kross KW; Heimdal JH; Olsnes C; Olofsson J; Aarstad HJ
Scand J Immunol; 2008 Apr; 67(4):392-9. PubMed ID: 18282234
[TBL] [Abstract][Full Text] [Related]
17. Activated T lymphocytes regulate hyaluronan binding to monocyte CD44 via production of IL-2 and IFN-gamma.
Levesque MC; Haynes BF
J Immunol; 2001 Jan; 166(1):188-96. PubMed ID: 11123292
[TBL] [Abstract][Full Text] [Related]
18. Peritumoral cuffing by T-cell tumor-infiltrating lymphocytes distinguishes HPV-related oropharyngeal squamous cell carcinoma from oral cavity squamous cell carcinoma.
Poropatich K; Hernandez D; Fontanarosa J; Brown K; Woloschak G; Paintal A; Raparia K; Samant S
J Oral Pathol Med; 2017 Nov; 46(10):972-978. PubMed ID: 28632936
[TBL] [Abstract][Full Text] [Related]
19. Human autologous monocytes and monocyte-derived macrophages in co-culture with carcinoma F-spheroids secrete IL-6 by a non-CD14-dependent pathway.
Heimdal JH; Aarstad HJ; Olsnes C; Olofsson J
Scand J Immunol; 2001 Feb; 53(2):162-70. PubMed ID: 11169220
[TBL] [Abstract][Full Text] [Related]
20. Disease stage related in vitro responsiveness of peripheral blood T-lymphocytes in patients with head and neck carcinoma.
Heimdal JH; Aarstad HJ; Klementsen B; Olofsson J
Acta Otolaryngol; 1998 Nov; 118(6):887-91. PubMed ID: 9870639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]